Cadrenal Therapeutics News

Cadrenal Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 12 02:06

H.C. Wainwright Maintains Cadrenal Therapeutics(CVKD.US) With Buy Rating, Cuts Target Price to $32

Futu NewsNov 8 23:31

Noble Financial Maintains Cadrenal Therapeutics(CVKD.US) With Buy Rating, Cuts Target Price to $45

Futu NewsNov 8 22:38

Analysts Are Bullish on These Healthcare Stocks: Joint (JYNT), Cadrenal Therapeutics, Inc. (CVKD)

TipRanksNov 8 22:36

Analysts' Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Cadrenal Therapeutics, Inc. (CVKD) and Allogene Therapeutics (ALLO)

TipRanksAug 8 22:04

Cadrenal Therapeutics Analyst Ratings

BenzingaJun 6 18:45

HC Wainwright & Co. : The Cadrenal Therapeutics (CVKD.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $3.00.

Zhitong FinanceMay 9 23:31

HC Wainwright & Co. Reiterates Buy on Cadrenal Therapeutics, Maintains $3 Price Target

BenzingaMay 9 23:30

Buy Rating Affirmed for Cadrenal Therapeutics on Strong Clinical and Financial Prospects

TipRanksMay 9 22:10

Cadrenal Therapeutics Analyst Ratings

BenzingaMar 14 19:35

Analysts Conflicted on These Healthcare Names: Cadrenal Therapeutics, Inc. (CVKD), Protara Therapeutics (TARA) and Spruce Biosciences (SPRB)

TipRanksMar 14 18:35

Cadrenal Therapeutics, Inc. (CVKD) Receives a Buy From Noble Financial

TipRanksMar 13 20:10

Noble Capital Markets Initiates Coverage On Cadrenal Therapeutics With Outperform Rating, Announces Price Target of $4

BenzingaDec 18, 2023 22:09

Cadrenal Therapeutics Analyst Ratings

BenzingaDec 18, 2023 22:07

HC Wainwright & Co. Initiates Coverage On Cadrenal Therapeutics With Buy Rating, Announces Price Target of $3

BenzingaNov 20, 2023 20:05

Cadrenal Therapeutics Analyst Ratings

BenzingaNov 20, 2023 20:04